Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An E2F-responsive promoter is a specific region of DNA containing E2F-binding sites, which serve as a platform for E2F family transcription factors to regulate the expression of nearby genes. E2F-responsive promoters are critical for controlling expression of genes involved in cell cycle progression, DNA replication, apoptosis, and proliferation. The activity of these promoters is tightly regulated by activating or repressing E2F proteins, often in cooperation with pocket proteins (such as pRB, p107, p130); their binding dynamically changes with cell cycle phase, contributing to either repression (in quiescence/early G1) or activation (late G1/S phase). Aberrant regulation at E2F-responsive promoters is associated with uncontrolled cell growth and cancer. However, these promoters are not direct drug targets; rather, their regulatory components—namely the E2F proteins—are the relevant biological targets.
Not applicable for drugs; mechanisms relate to transcription factor binding: - Activation/repression of gene transcription by E2F family members, modulated by pocket proteins such as pRB, p107, and p130
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E2F-responsive promoter (None).